Innate Pharma SA Retained Earnings (Accumulated Deficit) 2012-2023 | IPHYF
Innate Pharma SA retained earnings (accumulated deficit) from 2012 to 2023. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.